Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group (Q46312662)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group |
scientific article |
Statements
1 reference
Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group (English)
1 reference
Levine AM
1 reference
Li P
1 reference
Cheung T
1 reference
Tulpule A
1 reference
Von Roenn J
1 reference
Nathwani BN
1 reference
Ratner L
1 reference
1 August 2000
1 reference
24
1 reference
5
1 reference
444-450
1 reference
Identifiers
1 reference